Switching From Donepezil to Rivastigmine Is Well Tolerated: Results of an Open-Label Safety and Tolerability Study

Background: Transitioning patients between cholinesterase inhibitors was thought to require a washout period to avoid cholinergic toxicity; however, evidence suggests that abrupt discontinuation of donepezil may lead to cognitive decline. We evaluated the safety and tolerability of an immediate swit...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sadowsky, Carl H., Farlow, Martin R., Atkinson, Leone, Steadman, Jennifer, Koumaras, Barbara, Chen, Michael, Mirski, Dario
Natura: Artigo
Lingua:Inglês
Pubblicazione: Physicians Postgraduate Press, Inc. 2005
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1079694/
https://ncbi.nlm.nih.gov/pubmed/15841194
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi